share_log

欧普康视(300595.SZ)：旗下合肥康视眼科医院有0.01%的硫酸阿托品院内制剂

Opcom Vision (300595.SZ): Its Hefei Kangshi Ophthalmology Hospital has 0.01% of the in-hospital preparation of atropine sulphate

Gelonghui Finance ·  Mar 13 03:51

Gelonghui, March 13 | Opticon TV (300595.SZ) said on the investor interactive platform that the company's Hefei Kangshi Ophthalmology Hospital has 0.01% of the in-hospital preparation of atropine sulfate, which began to be sold in hospitals in July 2022, and optometry center users need to go to the hospital to buy them. After 0.01% atropine sulfate approved and registered by the State Drug Administration is marketed, in-hospital preparations of the same dose will no longer be produced and will be sold as products registered by the State Drug Administration. The company's holding subsidiary, the product 0.01% of atropine sulphate registered by the National Drug Administration, is in phase III clinical phase.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment